CDNA · Healthcare
CAREDX INC
Smart-money confidence
· 1 of 3 sources firing
Bearish — money moving out
No standout activity across the feeds we track.
Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in CAREDX INC? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$1.9B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGM
About CAREDX INC
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune…
Who's behind the signal
Every informed buyer we can see on CDNA, across all three feeds.
Hedge funds · 6
Gotham Asset Mgmt (Greenblatt)
New position
D.E. Shaw & Co
Increased +75%
Citadel Advisors
Increased +3%
AQR Capital Management
Increased +61%
ARK Invest (Cathie Wood)
Unchanged
Millennium Management (Englander)
Decreased −76%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 9
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-12-29 | Tom Malinowski · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2021-03-02 | Tom Malinowski · D-NJ | House | BOUGHT | $15,001 - $50,000 |
| 2021-01-11 | Tom Malinowski · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2021-01-08 | Tom Malinowski · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2021-01-06 | Tom Malinowski · D-NJ | House | SOLD | $15,001 - $50,000 |
| 2020-12-23 | Tom Malinowski · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-12-07 | Tom Malinowski · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-11-16 | Tom Malinowski · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-10-09 | Tom Malinowski · D-NJ | House | SOLD | $1,001 - $15,000 |
Not a model pick — but on our radar.
CAREDX INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
1
New positions
3
Increasing
1
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+75%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+3%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+61%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.3%
Position change
—
0.3% of ARK Invest's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−76%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to CAREDX INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell CAREDX INC or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime